SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sciele Pharma, Inc. and Plethora Solutions Holdings Announce Final Analysis of PSD502 for Premature Ejaculation; All Primary and Secondary Endpoints Met in Phase III Pivotal Trial